Thursday, March 30, 2023
Evolent Health announced an agreement to expand its Technology and Services solution for oncology with its existing partner, Centene Corporation.
Centene will expand its use of Evolent Health's oncology solution across its Centene and WellCare Medicare Advantage (MA) members nationally. This agreement deepens the speciality care partnership between Centene and Evolent in the MA market.
This expanded partnership with Centene enables its goal to provide the most valuable tools to manage the quality and cost of oncology care for Medicare Advantage members nationally and helps in achieving the common goal of optimizing oncology outcomes for all plan members, their families and caregivers.
